by Olivia K. Foster Rhoades On December 4th, President Trump declared both the Bears Ears National Monument and the Grand Staircase-Escalante would be reduced by 1 million acres each–an unprecedented change in federal land policy. As we near the end of 2017, four more monuments totaling 12.3 million acres in size have been slated for reduction. To put that in perspective, the state of Massachusetts … Continue reading The Scales of Federal Land Management: Balancing spacious skies and purple mountains of paperwork
by Felix Barber figures by Rebecca Senft Why are batteries important? Ask yourself what a future with a sustainable economy would look like. Such a future would likely exploit sources of renewable energy, such as solar and wind, to power the electric grid, with personal transport in the form of electric vehicles (“EVs”) that would draw their power from that same grid rather than from … Continue reading The Future of Energy Storage: A lost opportunity for the U.S.?
The world is currently experiencing its sixth mass extinction event. Species are disappearing at an estimated 1000x the expected normal rate of extinction (roughly 5 species per year). Conservation efforts around the world are trying to reduce the rate of biodiversity loss, but they are hindered by the lack of hard evidence linking conservation spending to biodiversity improvements. A team led by University of Oxford researchers … Continue reading Conservation spending proven to make a difference
by Katherine Wu My freshman year of college, I was given a choice: techie or fuzzy? And, before you ask, no, it wasn’t about creepy role-play. It was worse: my major. At Stanford, there were two kinds of people: those who studied the technical, hard science, and mathematics-based majors were “techie,” and those pursuing the humanities, arts, and social sciences were “fuzzy.” I chose biology … Continue reading How to be a Socially Conscious Scientist
Update: Since the writing of this article, Donald Trump has picked Scott Gottleib as FDA commissioner. -SITN editorial staff by Linda Honaker figures by Rebecca Clements Donald Trump will soon pick a new commissioner for the Federal Drug Administration (FDA). The choice will likely be someone who will try to make the administration’s drug approval requirements less rigorous in order to get drugs on the … Continue reading Make the FDA Great Again? Trump and the future of the drug approval process
According to the CDC, 70.7% of the US population is overweight or obese (BMI>30), with 37.9% being obese. Obesity related health expenses accounted for an estimated $147 billion in healthcare spending in 2008 alone. The dire health consequences for obese individuals include higher incidence of high blood pressure, type 2 diabetes and coronary heart disease to name a few on top of overall decrease in … Continue reading Parental weight and its impact on early childhood development
The first clinical trial using the gene editing technique CRISPR was given the go-ahead by panel from the US National Institutes of Health (NIH). The trial is aimed at determining if the technique is safe for use on human subjects. As there is much we have yet to learn about genes and their expression, it is a valid concern that modifying DNA in humans could … Continue reading First Human Trial of Gene Editing Technique CRISPR Approved